EYET
Eyetech Pharmaceuticals, Inc.
Biopharmaceutical company developing and commercializing treatments for retinal diseases, including Macugen (pegaptanib sodium), a first-in-class anti-VEGF therapy for wet age-related macular degeneration.
CUSIP: 302297106HealthcareUS1 holder